FDA and 23andme: why they did it

Why The FDA Can’t Be Flexible With 23andMe, By Law
David Kroll, forbes.com

“One of the challenges is the world has been evolving and yet we have legislation that reflects a different era.”– Margaret Hamburg, Commissioner, U.S. Food and Drug Administration

Almost a year ago, at the inau­gur­al Forbes…

http://flip.it/690F3

Related articles

• Why The FDA Can’t Be Flexible With 23andMe, By Law (forbes.com)
• FDA hacked, pharmaceutical companies push for online security audit (medcitynews.com)
• We Moved Forward on Many Fronts This Year | FDA Voice (drughealth.blogspot.com)